Camila Takeno Cologna
0000-0002-5789-9278
VIB Metabolomics Core Leuven
1 paper found
Refreshing results…
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
Missing publications? Search for publications with a matching author name.